合計 50 件の最近のインサイダー取引記録が記録されています Envista Holdings Corp (NVST), 内訳は 36 件の買い および 11 件の売り. インサイダー買い総額は $7.05M インサイダー売り総額は $3.39M.
最近活動のある主要インサイダーには Hammes Eric D., Keel Paul A, Nance Mark E. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — NVST
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-02-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU 付与(制限付株式) |
29,225 |
- |
- |
29,225 |
| 2026-02-25 |
Keel Paul A |
Chief Executive Officer |
RSU 付与(制限付株式) |
115,320 |
$29.59 |
$3.41M |
115,320 |
| 2026-02-25 |
Nance Mark E |
General Counsel |
RSU 付与(制限付株式) |
23,070 |
- |
- |
23,070 |
| 2026-02-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 付与(制限付株式) |
10,770 |
- |
- |
10,770 |
| 2026-02-25 |
Kaabi Faez C |
Chief Accounting Officer |
RSU 源泉徴収 |
4,964 |
$29.59 |
$146.88K |
45,032 |
| 2026-02-25 |
Befidi Robert |
President, Diagnostics |
RSU 付与(制限付株式) |
13,845 |
- |
- |
13,845 |
| 2026-02-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU 付与(制限付株式) |
13,845 |
- |
- |
13,845 |
| 2026-02-25 |
Acurio Veronica |
President, Orthodontics |
RSU 付与(制限付株式) |
13,845 |
- |
- |
13,845 |
| 2026-02-10 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
オプション行使(売却) |
5,634 |
$15.97 |
$89.97K |
- |
| 2026-02-01 |
Hammes Eric D. |
Chief Financial Officer |
RSU 付与(制限付株式) |
1,119 |
- |
- |
1,119 |
| 2026-02-01 |
Keel Paul A |
Chief Executive Officer |
RSU 付与(制限付株式) |
4,091 |
- |
- |
4,091 |
| 2026-02-01 |
Nance Mark E |
General Counsel |
RSU 付与(制限付株式) |
2,006 |
- |
- |
7,587 |
| 2026-02-01 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 付与(制限付株式) |
2,919 |
- |
- |
29,357 |
| 2026-02-01 |
Kaabi Faez C |
Chief Accounting Officer |
RSU 付与(制限付株式) |
1,186 |
- |
- |
5,040 |
| 2026-02-01 |
Befidi Robert |
President, Diagnostics |
RSU 付与(制限付株式) |
998 |
- |
- |
2,149 |
| 2026-02-01 |
Acurio Veronica |
President, Orthodontics |
RSU 付与(制限付株式) |
998 |
- |
- |
998 |
| 2025-11-01 |
Keel Paul A |
Chief Executive Officer |
RSU 源泉徴収 |
54,097 |
$20.35 |
$1.1M |
347,555 |
| 2025-08-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU 源泉徴収 |
7,654 |
$21.12 |
$161.65K |
96,788 |
| 2025-08-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
情報に基づく売り |
15,000 |
$21.60 |
$324K |
32,382 |
| 2025-08-25 |
Befidi Robert |
President, Diagnostics |
RSU 源泉徴収 |
3,454 |
$21.12 |
$72.95K |
45,504 |
| 2025-08-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU 源泉徴収 |
804 |
$21.12 |
$16.98K |
54,941 |
| 2025-08-25 |
Acurio Veronica |
President, Orthodontics |
RSU 源泉徴収 |
5,422 |
$21.12 |
$114.51K |
50,323 |
| 2025-07-14 |
Pierce James Andrew |
Director |
不明 |
- |
- |
- |
- |
| 2025-07-14 |
Pierce James Andrew |
Director |
RSU 付与(制限付株式) |
9,155 |
- |
- |
9,155 |
| 2025-06-10 |
Tsingos Christine A |
Director |
RSU 付与(制限付株式) |
10,450 |
- |
- |
50,600 |
| 2025-06-10 |
Raskas Daniel |
Director |
RSU 付与(制限付株式) |
10,450 |
- |
- |
44,680 |
| 2025-06-10 |
Gallahue Kieran |
Director |
RSU 付与(制限付株式) |
10,450 |
- |
- |
44,680 |
| 2025-06-10 |
Huennekens R Scott |
Director |
RSU 付与(制限付株式) |
14,370 |
- |
- |
69,520 |
| 2025-06-10 |
Jain Vivek |
Director |
RSU 付与(制限付株式) |
10,450 |
- |
- |
43,615 |
| 2025-06-10 |
Carruthers Wendy |
Director |
RSU 付与(制限付株式) |
10,450 |
- |
- |
50,610 |
| 2025-06-10 |
Hulit Barbara B. |
Director |
RSU 付与(制限付株式) |
10,450 |
- |
- |
79,820 |
| 2025-05-25 |
Keel Paul A |
Chief Executive Officer |
RSU 源泉徴収 |
12,787 |
$16.72 |
$213.8K |
401,652 |
| 2025-02-26 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 付与(制限付株式) |
8,475 |
- |
- |
47,382 |
| 2025-02-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU 付与(制限付株式) |
28,995 |
- |
- |
28,995 |
| 2025-02-25 |
Keel Paul A |
Chief Executive Officer |
RSU 付与(制限付株式) |
153,660 |
$20.66 |
$3.17M |
153,660 |
| 2025-02-25 |
Nance Mark E |
General Counsel |
RSU 付与(制限付株式) |
33,455 |
- |
- |
33,455 |
| 2025-02-25 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 付与(制限付株式) |
15,615 |
- |
- |
15,615 |
| 2025-02-25 |
Kaabi Faez C |
Chief Accounting Officer |
RSU 付与(制限付株式) |
22,600 |
$20.66 |
$466.92K |
22,600 |
| 2025-02-25 |
Befidi Robert |
President, Diagnostics |
RSU 付与(制限付株式) |
18,960 |
- |
- |
18,960 |
| 2025-02-25 |
Nilsson Stefan |
President, Nobel Biocare |
RSU 付与(制限付株式) |
18,960 |
- |
- |
18,960 |
| 2025-02-25 |
Acurio Veronica |
President, Orthodontics |
RSU 付与(制限付株式) |
18,960 |
- |
- |
18,960 |
| 2025-02-01 |
Nance Mark E |
General Counsel |
RSU 付与(制限付株式) |
965 |
- |
- |
5,581 |
| 2025-02-01 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 付与(制限付株式) |
3,152 |
- |
- |
26,438 |
| 2025-02-01 |
Kaabi Faez C |
Chief Accounting Officer |
RSU 付与(制限付株式) |
689 |
- |
- |
3,854 |
| 2025-02-01 |
Befidi Robert |
President, Diagnostics |
RSU 付与(制限付株式) |
1,151 |
- |
- |
1,151 |
| 2024-11-18 |
Nilsson Stefan |
President, Nobel Biocare |
不明 |
- |
- |
- |
45,455 |
| 2024-11-18 |
Acurio Veronica |
President, Orthodontics |
不明 |
- |
- |
- |
45,455 |
| 2024-11-01 |
Keel Paul A |
Chief Executive Officer |
RSU 源泉徴収 |
53,996 |
$20.94 |
$1.13M |
348,609 |
| 2024-09-17 |
Reis Mischa |
SVP, Strategy & Bus. Dev. |
RSU 源泉徴収 |
812 |
$19.00 |
$15.43K |
42,720 |
| 2024-08-25 |
Hammes Eric D. |
Chief Financial Officer |
RSU 付与(制限付株式) |
64,175 |
- |
- |
88,707 |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効